Market Closed -
Bombay S.E.
06:00:50 2024-04-26 am EDT
|
5-day change
|
1st Jan Change
|
206
INR
|
-1.44%
|
|
+1.73%
|
+41.34%
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
37,464
|
22,020
|
10,498
|
15,382
|
19,396
|
13,450
|
Enterprise Value (EV)
1 |
38,971
|
25,031
|
13,525
|
19,193
|
25,183
|
18,775
|
P/E ratio
|
39.7
x
|
24.7
x
|
29.7
x
|
10.6
x
|
13.3
x
|
22
x
|
Yield
|
0.68%
|
-
|
1.25%
|
1.57%
|
0.52%
|
2.01%
|
Capitalization / Revenue
|
3.65
x
|
2.1
x
|
0.94
x
|
1.16
x
|
1.24
x
|
0.8
x
|
EV / Revenue
|
3.8
x
|
2.39
x
|
1.21
x
|
1.45
x
|
1.61
x
|
1.11
x
|
EV / EBITDA
|
22.8
x
|
14.2
x
|
8.08
x
|
8.22
x
|
12
x
|
9.61
x
|
EV / FCF
|
-121
x
|
-28.4
x
|
11.5
x
|
19
x
|
-144
x
|
21.3
x
|
FCF Yield
|
-0.83%
|
-3.52%
|
8.68%
|
5.26%
|
-0.7%
|
4.7%
|
Price to Book
|
4.34
x
|
2.51
x
|
1.27
x
|
1.62
x
|
1.91
x
|
1.26
x
|
Nbr of stocks (in thousands)
|
144,621
|
143,594
|
137,947
|
138,014
|
135,114
|
135,175
|
Reference price
2 |
259.0
|
153.4
|
76.10
|
111.4
|
143.6
|
99.50
|
Announcement Date
|
8/10/18
|
7/15/19
|
8/8/20
|
7/14/21
|
7/12/22
|
7/19/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
10,251
|
10,481
|
11,142
|
13,220
|
15,642
|
16,865
|
EBITDA
1 |
1,706
|
1,760
|
1,674
|
2,335
|
2,103
|
1,953
|
EBIT
1 |
1,494
|
1,471
|
1,311
|
1,902
|
1,590
|
1,330
|
Operating Margin
|
14.57%
|
14.04%
|
11.77%
|
14.39%
|
10.16%
|
7.89%
|
Earnings before Tax (EBT)
1 |
1,448
|
1,153
|
544.8
|
1,935
|
1,323
|
1,044
|
Net income
1 |
941.9
|
884.8
|
356.9
|
1,447
|
1,486
|
611.7
|
Net margin
|
9.19%
|
8.44%
|
3.2%
|
10.95%
|
9.5%
|
3.63%
|
EPS
2 |
6.519
|
6.200
|
2.558
|
10.48
|
10.81
|
4.525
|
Free Cash Flow
1 |
-321.9
|
-881.2
|
1,174
|
1,010
|
-175.4
|
882.4
|
FCF margin
|
-3.14%
|
-8.41%
|
10.53%
|
7.64%
|
-1.12%
|
5.23%
|
FCF Conversion (EBITDA)
|
-
|
-
|
70.12%
|
43.28%
|
-
|
45.19%
|
FCF Conversion (Net income)
|
-
|
-
|
328.8%
|
69.83%
|
-
|
144.25%
|
Dividend per Share
2 |
1.750
|
-
|
0.9500
|
1.750
|
0.7500
|
2.000
|
Announcement Date
|
8/10/18
|
7/15/19
|
8/8/20
|
7/14/21
|
7/12/22
|
7/19/23
|
Fiscal Period: March |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
---|
Net sales
1 |
3,830
|
4,052
|
3,590
|
3,599
|
4,036
|
4,593
|
4,150
|
4,142
|
EBITDA
1 |
668.5
|
671.1
|
414.2
|
538.6
|
621
|
603
|
548.7
|
586.6
|
EBIT
1 |
500.1
|
489.3
|
242
|
365.1
|
449.9
|
402.1
|
350.8
|
382.4
|
Operating Margin
|
13.06%
|
12.08%
|
6.74%
|
10.14%
|
11.15%
|
8.76%
|
8.45%
|
9.23%
|
Earnings before Tax (EBT)
1 |
506.9
|
531.6
|
244
|
273
|
430.8
|
373.8
|
314.9
|
351.5
|
Net income
1 |
353.9
|
401.3
|
814.7
|
222.2
|
323.7
|
125
|
216
|
240.9
|
Net margin
|
9.24%
|
9.9%
|
22.69%
|
6.17%
|
8.02%
|
2.72%
|
5.2%
|
5.82%
|
EPS
2 |
2.560
|
2.910
|
5.900
|
1.610
|
2.350
|
0.9100
|
1.600
|
1.800
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
2/10/21
|
5/27/21
|
8/6/21
|
10/29/21
|
2/7/22
|
5/25/22
|
8/9/22
|
10/21/22
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
1,507
|
3,011
|
3,027
|
3,812
|
5,788
|
5,325
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
0.8831
x
|
1.711
x
|
1.809
x
|
1.633
x
|
2.753
x
|
2.727
x
|
Free Cash Flow
1 |
-322
|
-881
|
1,174
|
1,010
|
-175
|
882
|
ROE (net income / shareholders' equity)
|
11.3%
|
10.2%
|
4.2%
|
16.1%
|
14.6%
|
5.73%
|
ROA (Net income/ Total Assets)
|
7.92%
|
6.75%
|
5.59%
|
7.02%
|
4.74%
|
3.68%
|
Assets
1 |
11,889
|
13,110
|
6,390
|
20,617
|
31,368
|
16,624
|
Book Value Per Share
2 |
59.70
|
61.10
|
59.70
|
69.00
|
75.00
|
78.70
|
Cash Flow per Share
2 |
1.210
|
2.650
|
4.530
|
9.890
|
8.820
|
4.700
|
Capex
1 |
1,208
|
1,180
|
447
|
338
|
268
|
688
|
Capex / Sales
|
11.78%
|
11.26%
|
4.01%
|
2.55%
|
1.71%
|
4.08%
|
Announcement Date
|
8/10/18
|
7/15/19
|
8/8/20
|
7/14/21
|
7/12/22
|
7/19/23
|
|
1st Jan change
|
Capi.
|
---|
| +11.47% | 63.22B | | -3.47% | 46.34B | | +13.72% | 39.97B | | +17.83% | 25.46B | | +7.27% | 18.68B | | -0.57% | 17.24B | | -21.73% | 15.81B | | +0.22% | 14.9B | | -19.10% | 13.74B |
Other Specialty Chemicals
|